Global Mumps Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Mumps Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Mumps Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Mumps Drug market. Mumps Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Mumps Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Mumps Drug market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Mumps Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Mumps Drug market. It may include historical data, market segmentation by Type (e.g., RIT 4385, Schwarz), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Mumps Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Mumps Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Mumps Drug industry. This include advancements in Mumps Drug technology, Mumps Drug new entrants, Mumps Drug new investment, and other innovations that are shaping the future of Mumps Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Mumps Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Mumps Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Mumps Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Mumps Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Mumps Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Mumps Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Mumps Drug market.
Market Segmentation:
Mumps Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Mumps Drug market?
What factors are driving Mumps Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mumps Drug market opportunities vary by end market size?
How does Mumps Drug break out type, application?
According to our LPI (LP Information) latest study, the global Mumps Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Mumps Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Mumps Drug market. Mumps Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Mumps Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Mumps Drug market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Mumps Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Mumps Drug market. It may include historical data, market segmentation by Type (e.g., RIT 4385, Schwarz), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Mumps Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Mumps Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Mumps Drug industry. This include advancements in Mumps Drug technology, Mumps Drug new entrants, Mumps Drug new investment, and other innovations that are shaping the future of Mumps Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Mumps Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Mumps Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Mumps Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Mumps Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Mumps Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Mumps Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Mumps Drug market.
Market Segmentation:
Mumps Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- RIT 4385
- Schwarz
- Wistar RA 27/3
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Beijing Minhai Biotechnology Co., Ltd
- Beijing Tiantan Biological Products Co., Ltd.
- China National Pharmaceutical Group Corporation
- GlaxoSmithKline Plc
- Organic Vaccines
- Prometheon Pharma, LLC
- Sinovac Biotech Ltd.
- Zydus Cadila Healthcare Limited
What is the 10-year outlook for the global Mumps Drug market?
What factors are driving Mumps Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mumps Drug market opportunities vary by end market size?
How does Mumps Drug break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mumps Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Mumps Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Mumps Drug by Country/Region, 2019, 2023 & 2030
2.2 Mumps Drug Segment by Type
2.2.1 RIT 4385
2.2.2 Schwarz
2.2.3 Wistar RA 27/3
2.2.4 Others
2.3 Mumps Drug Sales by Type
2.3.1 Global Mumps Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Mumps Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Mumps Drug Sale Price by Type (2019-2024)
2.4 Mumps Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Mumps Drug Sales by Application
2.5.1 Global Mumps Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Mumps Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Mumps Drug Sale Price by Application (2019-2024)
3 GLOBAL MUMPS DRUG BY COMPANY
3.1 Global Mumps Drug Breakdown Data by Company
3.1.1 Global Mumps Drug Annual Sales by Company (2019-2024)
3.1.2 Global Mumps Drug Sales Market Share by Company (2019-2024)
3.2 Global Mumps Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Mumps Drug Revenue by Company (2019-2024)
3.2.2 Global Mumps Drug Revenue Market Share by Company (2019-2024)
3.3 Global Mumps Drug Sale Price by Company
3.4 Key Manufacturers Mumps Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mumps Drug Product Location Distribution
3.4.2 Players Mumps Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MUMPS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Mumps Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Mumps Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Mumps Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Mumps Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Mumps Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Mumps Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Mumps Drug Sales Growth
4.4 APAC Mumps Drug Sales Growth
4.5 Europe Mumps Drug Sales Growth
4.6 Middle East & Africa Mumps Drug Sales Growth
5 AMERICAS
5.1 Americas Mumps Drug Sales by Country
5.1.1 Americas Mumps Drug Sales by Country (2019-2024)
5.1.2 Americas Mumps Drug Revenue by Country (2019-2024)
5.2 Americas Mumps Drug Sales by Type
5.3 Americas Mumps Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mumps Drug Sales by Region
6.1.1 APAC Mumps Drug Sales by Region (2019-2024)
6.1.2 APAC Mumps Drug Revenue by Region (2019-2024)
6.2 APAC Mumps Drug Sales by Type
6.3 APAC Mumps Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mumps Drug by Country
7.1.1 Europe Mumps Drug Sales by Country (2019-2024)
7.1.2 Europe Mumps Drug Revenue by Country (2019-2024)
7.2 Europe Mumps Drug Sales by Type
7.3 Europe Mumps Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mumps Drug by Country
8.1.1 Middle East & Africa Mumps Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Mumps Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Mumps Drug Sales by Type
8.3 Middle East & Africa Mumps Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mumps Drug
10.3 Manufacturing Process Analysis of Mumps Drug
10.4 Industry Chain Structure of Mumps Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mumps Drug Distributors
11.3 Mumps Drug Customer
12 WORLD FORECAST REVIEW FOR MUMPS DRUG BY GEOGRAPHIC REGION
12.1 Global Mumps Drug Market Size Forecast by Region
12.1.1 Global Mumps Drug Forecast by Region (2025-2030)
12.1.2 Global Mumps Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mumps Drug Forecast by Type
12.7 Global Mumps Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Beijing Minhai Biotechnology Co., Ltd
13.1.1 Beijing Minhai Biotechnology Co., Ltd Company Information
13.1.2 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product Portfolios and Specifications
13.1.3 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Beijing Minhai Biotechnology Co., Ltd Main Business Overview
13.1.5 Beijing Minhai Biotechnology Co., Ltd Latest Developments
13.2 Beijing Tiantan Biological Products Co., Ltd.
13.2.1 Beijing Tiantan Biological Products Co., Ltd. Company Information
13.2.2 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product Portfolios and Specifications
13.2.3 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Beijing Tiantan Biological Products Co., Ltd. Main Business Overview
13.2.5 Beijing Tiantan Biological Products Co., Ltd. Latest Developments
13.3 China National Pharmaceutical Group Corporation
13.3.1 China National Pharmaceutical Group Corporation Company Information
13.3.2 China National Pharmaceutical Group Corporation Mumps Drug Product Portfolios and Specifications
13.3.3 China National Pharmaceutical Group Corporation Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 China National Pharmaceutical Group Corporation Main Business Overview
13.3.5 China National Pharmaceutical Group Corporation Latest Developments
13.4 GlaxoSmithKline Plc
13.4.1 GlaxoSmithKline Plc Company Information
13.4.2 GlaxoSmithKline Plc Mumps Drug Product Portfolios and Specifications
13.4.3 GlaxoSmithKline Plc Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 GlaxoSmithKline Plc Main Business Overview
13.4.5 GlaxoSmithKline Plc Latest Developments
13.5 Organic Vaccines
13.5.1 Organic Vaccines Company Information
13.5.2 Organic Vaccines Mumps Drug Product Portfolios and Specifications
13.5.3 Organic Vaccines Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Organic Vaccines Main Business Overview
13.5.5 Organic Vaccines Latest Developments
13.6 Prometheon Pharma, LLC
13.6.1 Prometheon Pharma, LLC Company Information
13.6.2 Prometheon Pharma, LLC Mumps Drug Product Portfolios and Specifications
13.6.3 Prometheon Pharma, LLC Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Prometheon Pharma, LLC Main Business Overview
13.6.5 Prometheon Pharma, LLC Latest Developments
13.7 Sinovac Biotech Ltd.
13.7.1 Sinovac Biotech Ltd. Company Information
13.7.2 Sinovac Biotech Ltd. Mumps Drug Product Portfolios and Specifications
13.7.3 Sinovac Biotech Ltd. Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sinovac Biotech Ltd. Main Business Overview
13.7.5 Sinovac Biotech Ltd. Latest Developments
13.8 Zydus Cadila Healthcare Limited
13.8.1 Zydus Cadila Healthcare Limited Company Information
13.8.2 Zydus Cadila Healthcare Limited Mumps Drug Product Portfolios and Specifications
13.8.3 Zydus Cadila Healthcare Limited Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Zydus Cadila Healthcare Limited Main Business Overview
13.8.5 Zydus Cadila Healthcare Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mumps Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Mumps Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Mumps Drug by Country/Region, 2019, 2023 & 2030
2.2 Mumps Drug Segment by Type
2.2.1 RIT 4385
2.2.2 Schwarz
2.2.3 Wistar RA 27/3
2.2.4 Others
2.3 Mumps Drug Sales by Type
2.3.1 Global Mumps Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Mumps Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Mumps Drug Sale Price by Type (2019-2024)
2.4 Mumps Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Mumps Drug Sales by Application
2.5.1 Global Mumps Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Mumps Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Mumps Drug Sale Price by Application (2019-2024)
3 GLOBAL MUMPS DRUG BY COMPANY
3.1 Global Mumps Drug Breakdown Data by Company
3.1.1 Global Mumps Drug Annual Sales by Company (2019-2024)
3.1.2 Global Mumps Drug Sales Market Share by Company (2019-2024)
3.2 Global Mumps Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Mumps Drug Revenue by Company (2019-2024)
3.2.2 Global Mumps Drug Revenue Market Share by Company (2019-2024)
3.3 Global Mumps Drug Sale Price by Company
3.4 Key Manufacturers Mumps Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mumps Drug Product Location Distribution
3.4.2 Players Mumps Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MUMPS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Mumps Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Mumps Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Mumps Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Mumps Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Mumps Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Mumps Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Mumps Drug Sales Growth
4.4 APAC Mumps Drug Sales Growth
4.5 Europe Mumps Drug Sales Growth
4.6 Middle East & Africa Mumps Drug Sales Growth
5 AMERICAS
5.1 Americas Mumps Drug Sales by Country
5.1.1 Americas Mumps Drug Sales by Country (2019-2024)
5.1.2 Americas Mumps Drug Revenue by Country (2019-2024)
5.2 Americas Mumps Drug Sales by Type
5.3 Americas Mumps Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mumps Drug Sales by Region
6.1.1 APAC Mumps Drug Sales by Region (2019-2024)
6.1.2 APAC Mumps Drug Revenue by Region (2019-2024)
6.2 APAC Mumps Drug Sales by Type
6.3 APAC Mumps Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mumps Drug by Country
7.1.1 Europe Mumps Drug Sales by Country (2019-2024)
7.1.2 Europe Mumps Drug Revenue by Country (2019-2024)
7.2 Europe Mumps Drug Sales by Type
7.3 Europe Mumps Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mumps Drug by Country
8.1.1 Middle East & Africa Mumps Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Mumps Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Mumps Drug Sales by Type
8.3 Middle East & Africa Mumps Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mumps Drug
10.3 Manufacturing Process Analysis of Mumps Drug
10.4 Industry Chain Structure of Mumps Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mumps Drug Distributors
11.3 Mumps Drug Customer
12 WORLD FORECAST REVIEW FOR MUMPS DRUG BY GEOGRAPHIC REGION
12.1 Global Mumps Drug Market Size Forecast by Region
12.1.1 Global Mumps Drug Forecast by Region (2025-2030)
12.1.2 Global Mumps Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mumps Drug Forecast by Type
12.7 Global Mumps Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Beijing Minhai Biotechnology Co., Ltd
13.1.1 Beijing Minhai Biotechnology Co., Ltd Company Information
13.1.2 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product Portfolios and Specifications
13.1.3 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Beijing Minhai Biotechnology Co., Ltd Main Business Overview
13.1.5 Beijing Minhai Biotechnology Co., Ltd Latest Developments
13.2 Beijing Tiantan Biological Products Co., Ltd.
13.2.1 Beijing Tiantan Biological Products Co., Ltd. Company Information
13.2.2 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product Portfolios and Specifications
13.2.3 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Beijing Tiantan Biological Products Co., Ltd. Main Business Overview
13.2.5 Beijing Tiantan Biological Products Co., Ltd. Latest Developments
13.3 China National Pharmaceutical Group Corporation
13.3.1 China National Pharmaceutical Group Corporation Company Information
13.3.2 China National Pharmaceutical Group Corporation Mumps Drug Product Portfolios and Specifications
13.3.3 China National Pharmaceutical Group Corporation Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 China National Pharmaceutical Group Corporation Main Business Overview
13.3.5 China National Pharmaceutical Group Corporation Latest Developments
13.4 GlaxoSmithKline Plc
13.4.1 GlaxoSmithKline Plc Company Information
13.4.2 GlaxoSmithKline Plc Mumps Drug Product Portfolios and Specifications
13.4.3 GlaxoSmithKline Plc Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 GlaxoSmithKline Plc Main Business Overview
13.4.5 GlaxoSmithKline Plc Latest Developments
13.5 Organic Vaccines
13.5.1 Organic Vaccines Company Information
13.5.2 Organic Vaccines Mumps Drug Product Portfolios and Specifications
13.5.3 Organic Vaccines Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Organic Vaccines Main Business Overview
13.5.5 Organic Vaccines Latest Developments
13.6 Prometheon Pharma, LLC
13.6.1 Prometheon Pharma, LLC Company Information
13.6.2 Prometheon Pharma, LLC Mumps Drug Product Portfolios and Specifications
13.6.3 Prometheon Pharma, LLC Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Prometheon Pharma, LLC Main Business Overview
13.6.5 Prometheon Pharma, LLC Latest Developments
13.7 Sinovac Biotech Ltd.
13.7.1 Sinovac Biotech Ltd. Company Information
13.7.2 Sinovac Biotech Ltd. Mumps Drug Product Portfolios and Specifications
13.7.3 Sinovac Biotech Ltd. Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sinovac Biotech Ltd. Main Business Overview
13.7.5 Sinovac Biotech Ltd. Latest Developments
13.8 Zydus Cadila Healthcare Limited
13.8.1 Zydus Cadila Healthcare Limited Company Information
13.8.2 Zydus Cadila Healthcare Limited Mumps Drug Product Portfolios and Specifications
13.8.3 Zydus Cadila Healthcare Limited Mumps Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Zydus Cadila Healthcare Limited Main Business Overview
13.8.5 Zydus Cadila Healthcare Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mumps Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Mumps Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of RIT 4385
Table 4. Major Players of Schwarz
Table 5. Major Players of Wistar RA 27/3
Table 6. Major Players of Others
Table 7. Global Mumps Drug Sales by Type (2019-2024) & (K Pcs)
Table 8. Global Mumps Drug Sales Market Share by Type (2019-2024)
Table 9. Global Mumps Drug Revenue by Type (2019-2024) & ($ million)
Table 10. Global Mumps Drug Revenue Market Share by Type (2019-2024)
Table 11. Global Mumps Drug Sale Price by Type (2019-2024) & (USD/Pcs)
Table 12. Global Mumps Drug Sales by Application (2019-2024) & (K Pcs)
Table 13. Global Mumps Drug Sales Market Share by Application (2019-2024)
Table 14. Global Mumps Drug Revenue by Application (2019-2024)
Table 15. Global Mumps Drug Revenue Market Share by Application (2019-2024)
Table 16. Global Mumps Drug Sale Price by Application (2019-2024) & (USD/Pcs)
Table 17. Global Mumps Drug Sales by Company (2019-2024) & (K Pcs)
Table 18. Global Mumps Drug Sales Market Share by Company (2019-2024)
Table 19. Global Mumps Drug Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Mumps Drug Revenue Market Share by Company (2019-2024)
Table 21. Global Mumps Drug Sale Price by Company (2019-2024) & (USD/Pcs)
Table 22. Key Manufacturers Mumps Drug Producing Area Distribution and Sales Area
Table 23. Players Mumps Drug Products Offered
Table 24. Mumps Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Mumps Drug Sales by Geographic Region (2019-2024) & (K Pcs)
Table 28. Global Mumps Drug Sales Market Share Geographic Region (2019-2024)
Table 29. Global Mumps Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Mumps Drug Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Mumps Drug Sales by Country/Region (2019-2024) & (K Pcs)
Table 32. Global Mumps Drug Sales Market Share by Country/Region (2019-2024)
Table 33. Global Mumps Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Mumps Drug Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Mumps Drug Sales by Country (2019-2024) & (K Pcs)
Table 36. Americas Mumps Drug Sales Market Share by Country (2019-2024)
Table 37. Americas Mumps Drug Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Mumps Drug Revenue Market Share by Country (2019-2024)
Table 39. Americas Mumps Drug Sales by Type (2019-2024) & (K Pcs)
Table 40. Americas Mumps Drug Sales by Application (2019-2024) & (K Pcs)
Table 41. APAC Mumps Drug Sales by Region (2019-2024) & (K Pcs)
Table 42. APAC Mumps Drug Sales Market Share by Region (2019-2024)
Table 43. APAC Mumps Drug Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Mumps Drug Revenue Market Share by Region (2019-2024)
Table 45. APAC Mumps Drug Sales by Type (2019-2024) & (K Pcs)
Table 46. APAC Mumps Drug Sales by Application (2019-2024) & (K Pcs)
Table 47. Europe Mumps Drug Sales by Country (2019-2024) & (K Pcs)
Table 48. Europe Mumps Drug Sales Market Share by Country (2019-2024)
Table 49. Europe Mumps Drug Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Mumps Drug Revenue Market Share by Country (2019-2024)
Table 51. Europe Mumps Drug Sales by Type (2019-2024) & (K Pcs)
Table 52. Europe Mumps Drug Sales by Application (2019-2024) & (K Pcs)
Table 53. Middle East & Africa Mumps Drug Sales by Country (2019-2024) & (K Pcs)
Table 54. Middle East & Africa Mumps Drug Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Mumps Drug Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Mumps Drug Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Mumps Drug Sales by Type (2019-2024) & (K Pcs)
Table 58. Middle East & Africa Mumps Drug Sales by Application (2019-2024) & (K Pcs)
Table 59. Key Market Drivers & Growth Opportunities of Mumps Drug
Table 60. Key Market Challenges & Risks of Mumps Drug
Table 61. Key Industry Trends of Mumps Drug
Table 62. Mumps Drug Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Mumps Drug Distributors List
Table 65. Mumps Drug Customer List
Table 66. Global Mumps Drug Sales Forecast by Region (2025-2030) & (K Pcs)
Table 67. Global Mumps Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Mumps Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 69. Americas Mumps Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Mumps Drug Sales Forecast by Region (2025-2030) & (K Pcs)
Table 71. APAC Mumps Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Mumps Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 73. Europe Mumps Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Mumps Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 75. Middle East & Africa Mumps Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Mumps Drug Sales Forecast by Type (2025-2030) & (K Pcs)
Table 77. Global Mumps Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Mumps Drug Sales Forecast by Application (2025-2030) & (K Pcs)
Table 79. Global Mumps Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Beijing Minhai Biotechnology Co., Ltd Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product Portfolios and Specifications
Table 82. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Beijing Minhai Biotechnology Co., Ltd Main Business
Table 84. Beijing Minhai Biotechnology Co., Ltd Latest Developments
Table 85. Beijing Tiantan Biological Products Co., Ltd. Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product Portfolios and Specifications
Table 87. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Beijing Tiantan Biological Products Co., Ltd. Main Business
Table 89. Beijing Tiantan Biological Products Co., Ltd. Latest Developments
Table 90. China National Pharmaceutical Group Corporation Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. China National Pharmaceutical Group Corporation Mumps Drug Product Portfolios and Specifications
Table 92. China National Pharmaceutical Group Corporation Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. China National Pharmaceutical Group Corporation Main Business
Table 94. China National Pharmaceutical Group Corporation Latest Developments
Table 95. GlaxoSmithKline Plc Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. GlaxoSmithKline Plc Mumps Drug Product Portfolios and Specifications
Table 97. GlaxoSmithKline Plc Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. GlaxoSmithKline Plc Main Business
Table 99. GlaxoSmithKline Plc Latest Developments
Table 100. Organic Vaccines Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Organic Vaccines Mumps Drug Product Portfolios and Specifications
Table 102. Organic Vaccines Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. Organic Vaccines Main Business
Table 104. Organic Vaccines Latest Developments
Table 105. Prometheon Pharma, LLC Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Prometheon Pharma, LLC Mumps Drug Product Portfolios and Specifications
Table 107. Prometheon Pharma, LLC Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. Prometheon Pharma, LLC Main Business
Table 109. Prometheon Pharma, LLC Latest Developments
Table 110. Sinovac Biotech Ltd. Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Sinovac Biotech Ltd. Mumps Drug Product Portfolios and Specifications
Table 112. Sinovac Biotech Ltd. Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. Sinovac Biotech Ltd. Main Business
Table 114. Sinovac Biotech Ltd. Latest Developments
Table 115. Zydus Cadila Healthcare Limited Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Zydus Cadila Healthcare Limited Mumps Drug Product Portfolios and Specifications
Table 117. Zydus Cadila Healthcare Limited Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. Zydus Cadila Healthcare Limited Main Business
Table 119. Zydus Cadila Healthcare Limited Latest Developments
Table 1. Mumps Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Mumps Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of RIT 4385
Table 4. Major Players of Schwarz
Table 5. Major Players of Wistar RA 27/3
Table 6. Major Players of Others
Table 7. Global Mumps Drug Sales by Type (2019-2024) & (K Pcs)
Table 8. Global Mumps Drug Sales Market Share by Type (2019-2024)
Table 9. Global Mumps Drug Revenue by Type (2019-2024) & ($ million)
Table 10. Global Mumps Drug Revenue Market Share by Type (2019-2024)
Table 11. Global Mumps Drug Sale Price by Type (2019-2024) & (USD/Pcs)
Table 12. Global Mumps Drug Sales by Application (2019-2024) & (K Pcs)
Table 13. Global Mumps Drug Sales Market Share by Application (2019-2024)
Table 14. Global Mumps Drug Revenue by Application (2019-2024)
Table 15. Global Mumps Drug Revenue Market Share by Application (2019-2024)
Table 16. Global Mumps Drug Sale Price by Application (2019-2024) & (USD/Pcs)
Table 17. Global Mumps Drug Sales by Company (2019-2024) & (K Pcs)
Table 18. Global Mumps Drug Sales Market Share by Company (2019-2024)
Table 19. Global Mumps Drug Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Mumps Drug Revenue Market Share by Company (2019-2024)
Table 21. Global Mumps Drug Sale Price by Company (2019-2024) & (USD/Pcs)
Table 22. Key Manufacturers Mumps Drug Producing Area Distribution and Sales Area
Table 23. Players Mumps Drug Products Offered
Table 24. Mumps Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Mumps Drug Sales by Geographic Region (2019-2024) & (K Pcs)
Table 28. Global Mumps Drug Sales Market Share Geographic Region (2019-2024)
Table 29. Global Mumps Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Mumps Drug Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Mumps Drug Sales by Country/Region (2019-2024) & (K Pcs)
Table 32. Global Mumps Drug Sales Market Share by Country/Region (2019-2024)
Table 33. Global Mumps Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Mumps Drug Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Mumps Drug Sales by Country (2019-2024) & (K Pcs)
Table 36. Americas Mumps Drug Sales Market Share by Country (2019-2024)
Table 37. Americas Mumps Drug Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Mumps Drug Revenue Market Share by Country (2019-2024)
Table 39. Americas Mumps Drug Sales by Type (2019-2024) & (K Pcs)
Table 40. Americas Mumps Drug Sales by Application (2019-2024) & (K Pcs)
Table 41. APAC Mumps Drug Sales by Region (2019-2024) & (K Pcs)
Table 42. APAC Mumps Drug Sales Market Share by Region (2019-2024)
Table 43. APAC Mumps Drug Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Mumps Drug Revenue Market Share by Region (2019-2024)
Table 45. APAC Mumps Drug Sales by Type (2019-2024) & (K Pcs)
Table 46. APAC Mumps Drug Sales by Application (2019-2024) & (K Pcs)
Table 47. Europe Mumps Drug Sales by Country (2019-2024) & (K Pcs)
Table 48. Europe Mumps Drug Sales Market Share by Country (2019-2024)
Table 49. Europe Mumps Drug Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Mumps Drug Revenue Market Share by Country (2019-2024)
Table 51. Europe Mumps Drug Sales by Type (2019-2024) & (K Pcs)
Table 52. Europe Mumps Drug Sales by Application (2019-2024) & (K Pcs)
Table 53. Middle East & Africa Mumps Drug Sales by Country (2019-2024) & (K Pcs)
Table 54. Middle East & Africa Mumps Drug Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Mumps Drug Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Mumps Drug Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Mumps Drug Sales by Type (2019-2024) & (K Pcs)
Table 58. Middle East & Africa Mumps Drug Sales by Application (2019-2024) & (K Pcs)
Table 59. Key Market Drivers & Growth Opportunities of Mumps Drug
Table 60. Key Market Challenges & Risks of Mumps Drug
Table 61. Key Industry Trends of Mumps Drug
Table 62. Mumps Drug Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Mumps Drug Distributors List
Table 65. Mumps Drug Customer List
Table 66. Global Mumps Drug Sales Forecast by Region (2025-2030) & (K Pcs)
Table 67. Global Mumps Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Mumps Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 69. Americas Mumps Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Mumps Drug Sales Forecast by Region (2025-2030) & (K Pcs)
Table 71. APAC Mumps Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Mumps Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 73. Europe Mumps Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Mumps Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 75. Middle East & Africa Mumps Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Mumps Drug Sales Forecast by Type (2025-2030) & (K Pcs)
Table 77. Global Mumps Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Mumps Drug Sales Forecast by Application (2025-2030) & (K Pcs)
Table 79. Global Mumps Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Beijing Minhai Biotechnology Co., Ltd Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product Portfolios and Specifications
Table 82. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Beijing Minhai Biotechnology Co., Ltd Main Business
Table 84. Beijing Minhai Biotechnology Co., Ltd Latest Developments
Table 85. Beijing Tiantan Biological Products Co., Ltd. Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product Portfolios and Specifications
Table 87. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Beijing Tiantan Biological Products Co., Ltd. Main Business
Table 89. Beijing Tiantan Biological Products Co., Ltd. Latest Developments
Table 90. China National Pharmaceutical Group Corporation Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. China National Pharmaceutical Group Corporation Mumps Drug Product Portfolios and Specifications
Table 92. China National Pharmaceutical Group Corporation Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. China National Pharmaceutical Group Corporation Main Business
Table 94. China National Pharmaceutical Group Corporation Latest Developments
Table 95. GlaxoSmithKline Plc Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. GlaxoSmithKline Plc Mumps Drug Product Portfolios and Specifications
Table 97. GlaxoSmithKline Plc Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. GlaxoSmithKline Plc Main Business
Table 99. GlaxoSmithKline Plc Latest Developments
Table 100. Organic Vaccines Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Organic Vaccines Mumps Drug Product Portfolios and Specifications
Table 102. Organic Vaccines Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. Organic Vaccines Main Business
Table 104. Organic Vaccines Latest Developments
Table 105. Prometheon Pharma, LLC Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Prometheon Pharma, LLC Mumps Drug Product Portfolios and Specifications
Table 107. Prometheon Pharma, LLC Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. Prometheon Pharma, LLC Main Business
Table 109. Prometheon Pharma, LLC Latest Developments
Table 110. Sinovac Biotech Ltd. Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Sinovac Biotech Ltd. Mumps Drug Product Portfolios and Specifications
Table 112. Sinovac Biotech Ltd. Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. Sinovac Biotech Ltd. Main Business
Table 114. Sinovac Biotech Ltd. Latest Developments
Table 115. Zydus Cadila Healthcare Limited Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Zydus Cadila Healthcare Limited Mumps Drug Product Portfolios and Specifications
Table 117. Zydus Cadila Healthcare Limited Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. Zydus Cadila Healthcare Limited Main Business
Table 119. Zydus Cadila Healthcare Limited Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mumps Drug
Figure 2. Mumps Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mumps Drug Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Mumps Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Mumps Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of RIT 4385
Figure 10. Product Picture of Schwarz
Figure 11. Product Picture of Wistar RA 27/3
Figure 12. Product Picture of Others
Figure 13. Global Mumps Drug Sales Market Share by Type in 2023
Figure 14. Global Mumps Drug Revenue Market Share by Type (2019-2024)
Figure 15. Mumps Drug Consumed in Hospital
Figure 16. Global Mumps Drug Market: Hospital (2019-2024) & (K Pcs)
Figure 17. Mumps Drug Consumed in Clinic
Figure 18. Global Mumps Drug Market: Clinic (2019-2024) & (K Pcs)
Figure 19. Mumps Drug Consumed in Others
Figure 20. Global Mumps Drug Market: Others (2019-2024) & (K Pcs)
Figure 21. Global Mumps Drug Sales Market Share by Application (2023)
Figure 22. Global Mumps Drug Revenue Market Share by Application in 2023
Figure 23. Mumps Drug Sales Market by Company in 2023 (K Pcs)
Figure 24. Global Mumps Drug Sales Market Share by Company in 2023
Figure 25. Mumps Drug Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Mumps Drug Revenue Market Share by Company in 2023
Figure 27. Global Mumps Drug Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Mumps Drug Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Mumps Drug Sales 2019-2024 (K Pcs)
Figure 30. Americas Mumps Drug Revenue 2019-2024 ($ Millions)
Figure 31. APAC Mumps Drug Sales 2019-2024 (K Pcs)
Figure 32. APAC Mumps Drug Revenue 2019-2024 ($ Millions)
Figure 33. Europe Mumps Drug Sales 2019-2024 (K Pcs)
Figure 34. Europe Mumps Drug Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Mumps Drug Sales 2019-2024 (K Pcs)
Figure 36. Middle East & Africa Mumps Drug Revenue 2019-2024 ($ Millions)
Figure 37. Americas Mumps Drug Sales Market Share by Country in 2023
Figure 38. Americas Mumps Drug Revenue Market Share by Country in 2023
Figure 39. Americas Mumps Drug Sales Market Share by Type (2019-2024)
Figure 40. Americas Mumps Drug Sales Market Share by Application (2019-2024)
Figure 41. United States Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Mumps Drug Sales Market Share by Region in 2023
Figure 46. APAC Mumps Drug Revenue Market Share by Regions in 2023
Figure 47. APAC Mumps Drug Sales Market Share by Type (2019-2024)
Figure 48. APAC Mumps Drug Sales Market Share by Application (2019-2024)
Figure 49. China Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Mumps Drug Sales Market Share by Country in 2023
Figure 57. Europe Mumps Drug Revenue Market Share by Country in 2023
Figure 58. Europe Mumps Drug Sales Market Share by Type (2019-2024)
Figure 59. Europe Mumps Drug Sales Market Share by Application (2019-2024)
Figure 60. Germany Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Mumps Drug Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Mumps Drug Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Mumps Drug Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Mumps Drug Sales Market Share by Application (2019-2024)
Figure 69. Egypt Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Mumps Drug in 2023
Figure 75. Manufacturing Process Analysis of Mumps Drug
Figure 76. Industry Chain Structure of Mumps Drug
Figure 77. Channels of Distribution
Figure 78. Global Mumps Drug Sales Market Forecast by Region (2025-2030)
Figure 79. Global Mumps Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Mumps Drug Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Mumps Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Mumps Drug Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Mumps Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Mumps Drug
Figure 2. Mumps Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mumps Drug Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Mumps Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Mumps Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of RIT 4385
Figure 10. Product Picture of Schwarz
Figure 11. Product Picture of Wistar RA 27/3
Figure 12. Product Picture of Others
Figure 13. Global Mumps Drug Sales Market Share by Type in 2023
Figure 14. Global Mumps Drug Revenue Market Share by Type (2019-2024)
Figure 15. Mumps Drug Consumed in Hospital
Figure 16. Global Mumps Drug Market: Hospital (2019-2024) & (K Pcs)
Figure 17. Mumps Drug Consumed in Clinic
Figure 18. Global Mumps Drug Market: Clinic (2019-2024) & (K Pcs)
Figure 19. Mumps Drug Consumed in Others
Figure 20. Global Mumps Drug Market: Others (2019-2024) & (K Pcs)
Figure 21. Global Mumps Drug Sales Market Share by Application (2023)
Figure 22. Global Mumps Drug Revenue Market Share by Application in 2023
Figure 23. Mumps Drug Sales Market by Company in 2023 (K Pcs)
Figure 24. Global Mumps Drug Sales Market Share by Company in 2023
Figure 25. Mumps Drug Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Mumps Drug Revenue Market Share by Company in 2023
Figure 27. Global Mumps Drug Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Mumps Drug Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Mumps Drug Sales 2019-2024 (K Pcs)
Figure 30. Americas Mumps Drug Revenue 2019-2024 ($ Millions)
Figure 31. APAC Mumps Drug Sales 2019-2024 (K Pcs)
Figure 32. APAC Mumps Drug Revenue 2019-2024 ($ Millions)
Figure 33. Europe Mumps Drug Sales 2019-2024 (K Pcs)
Figure 34. Europe Mumps Drug Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Mumps Drug Sales 2019-2024 (K Pcs)
Figure 36. Middle East & Africa Mumps Drug Revenue 2019-2024 ($ Millions)
Figure 37. Americas Mumps Drug Sales Market Share by Country in 2023
Figure 38. Americas Mumps Drug Revenue Market Share by Country in 2023
Figure 39. Americas Mumps Drug Sales Market Share by Type (2019-2024)
Figure 40. Americas Mumps Drug Sales Market Share by Application (2019-2024)
Figure 41. United States Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Mumps Drug Sales Market Share by Region in 2023
Figure 46. APAC Mumps Drug Revenue Market Share by Regions in 2023
Figure 47. APAC Mumps Drug Sales Market Share by Type (2019-2024)
Figure 48. APAC Mumps Drug Sales Market Share by Application (2019-2024)
Figure 49. China Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Mumps Drug Sales Market Share by Country in 2023
Figure 57. Europe Mumps Drug Revenue Market Share by Country in 2023
Figure 58. Europe Mumps Drug Sales Market Share by Type (2019-2024)
Figure 59. Europe Mumps Drug Sales Market Share by Application (2019-2024)
Figure 60. Germany Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Mumps Drug Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Mumps Drug Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Mumps Drug Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Mumps Drug Sales Market Share by Application (2019-2024)
Figure 69. Egypt Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Mumps Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Mumps Drug in 2023
Figure 75. Manufacturing Process Analysis of Mumps Drug
Figure 76. Industry Chain Structure of Mumps Drug
Figure 77. Channels of Distribution
Figure 78. Global Mumps Drug Sales Market Forecast by Region (2025-2030)
Figure 79. Global Mumps Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Mumps Drug Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Mumps Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Mumps Drug Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Mumps Drug Revenue Market Share Forecast by Application (2025-2030)
